Biocon $200m dual trancher loan nets five
Indian pharmaceutical major Biocon, which approached the overseas loan market in July for a $200m loan, has seen five lenders join the syndicate.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts